Quoted: “Once you really solve a problem like direct brain-computer interface … when brains and computers can interact directly, to take just one example, that’s it, that’s the end of history, that’s the end of biology as we know it. Nobody has a clue what will happen once you solve this. If life can basically break out of the organic realm into the vastness of the inorganic realm, you cannot even begin to imagine what the consequences will be, because your imagination at present is organic. So if there is a point of Singularity, as it’s often referred to, by definition, we have no way of even starting to imagine what’s happening beyond that.”
“Obviously, it’s not a thoroughly vetted concept, but I think it’s extremely intriguing where drones might show up,” says Mark Rolston, founder of argodesign. “It would be nice to see them used this way, rather than another military function or more photography.”
The idea was born from a team brainstorming session around how health care could become more accessible. The designers first thought about how they could build a better ambulance, and the rise of autonomous vehicles inspired them to consider a self-driving ambulance. Then they thought of helicopters and drones, and the rest developed from there.
The study of consciousness and what makes us individuals is a topic filled with complexities. From a neuroscience perspective, consciousness is derived from a self-model as a unitary structure that shapes our perceptions, decisions and feelings. There is a tendency to jump to the conclusion with this model that mankind is being defined as self-absorbed and only being in it for ourselves in this life. Although that may be partially true, this definition of consciousness doesn’t necessarily address the role of morals and how that is shaped into our being. In the latest addition to The Galactic Public Archives, Dr. Ken Hayworth tackles the philosophical impact that technologies have on our lives.
Our previous two films feature Dr. Hayworth extrapolating about what radical new technologies in neuroscience could eventually produce. In a hypothetical world where mind upload is possible and we could create a perfect replica of ourselves, how would one personally identify? If this copy has the same memories and biological components, our method of understanding consciousness would inevitably shift. But when it comes down it, if we were put in a situation where it would be either you or the replica – it’s natural evolutionary instinct to want to save ourselves even if the other is an exact copy. This notion challenges the idea that our essence is defined by our life experiences because many different people can have identical experiences yet react differently.
Hayworth explains, that although there is an instinct for self-survival, humanity for the most part, has a basic understanding not to cause harm upon others. This is because morals are not being developed in the “hard drive” of your life experiences; instead our morals are tied to the very idea of someone just being a conscious and connected member of this world. Hayworth rationalizes that once we accept our flawed intuition of self, humanity will come to a spiritual understanding that the respect we give to others for simply possessing a reflection of the same kind of consciousness will be the key to us identifying our ultimate interconnectedness.
A few paralyzed patients could soon be using a wireless brain-computer interface able to stream their thought commands as quickly as a home Internet connection.
After more than a decade of engineering work, researchers at Brown University and a Utah company, Blackrock Microsystems, have commercialized a wireless device that can be attached to a person’s skull and transmit via radio thought commands collected from a brain implant. Blackrock says it will seek clearance for the system from the U.S. Food and Drug Administration, so that the mental remote control can be tested in volunteers, possibly as soon as this year.
The device was developed by a consortium, called BrainGate, which is based at Brown and was among the first to place implants in the brains of paralyzed people and show that electrical signals emitted by neurons inside the cortex could be recorded, then used to steer a wheelchair or direct a robotic arm (see “Implanting Hope”).
“No, no it’s not science fiction; it’s already happening,” said Ido Bachelet to a somewhat incredulous audience member at a London event late last year. Bachelet, previously of Harvard’s Wyss Institute and faculty member at Israel’s Bar-Ilan University, is a leading figure in the field of DNA nanotechnology.
In a brief talk, Bachelet said DNA nanobots will soon be tried in a critically ill leukemia patient. The patient, who has been given roughly six months to live, will receive an injection of DNA nanobots designed to interact with and destroy leukemia cells—while causing virtually zero collateral damage in healthy tissue.
In 2012, University of Pittsburgh researchers released a video of Jan Scheuermann feeding herself a bite of chocolate. This, of course, wouldn’t be noteworthy but for one thing: Scheuermann is paralyzed from the neck down. She fed herself that chocolate using a brain implant and thought-controlled robotic arm—and got a taste of freedom once unthinkable.
Scheuermann’s spinocerebellar degeneration left her unable to move her limbs over a decade ago. She leapt at the chance to take part in the University of Pittsburgh study investigating brain-computer interfaces. The study’s researchers are developing a system that reads and decodes brain activity, translating it into physical action in a robotic arm and hand.
So if I asked what you think will fuel the growth of today’s technology giants in the next 15 years, what would your answer be? You might say familiar or trendy terms, such as user growth or the Internet of Things. Or perhaps that the companies with the most innovative products and services will reign king in tomorrow’s tech markets. And while those are likely partially correct answers, there’s a tremendous amount of growth to be had from a rather unlikely source.
It might be difficult to believe that companies that have traditionally relied on silicon chips, mobile apps, and lines of software code could profit from something as seemingly disconnected as making biological engineering as predictable as traditional engineering fields, but a closer look into research and development spending hints that it may not be that far-fetched after all. Why are Autodesk (NASDAQ: ADSK) , Intel (NASDAQ: INTC) , and Microsoft (NASDAQ: MSFT) quietly investing in synthetic biology, and what could it mean for investors?
Quoted: “Legendary cyberculture icon (and iconoclast) R.U. Sirius and Jay Cornell have written a delicious funcyclopedia of the Singularity, transhumanism, and radical futurism, just published on January 1.” And: “The book, “Transcendence – The Disinformation Encyclopedia of Transhumanism and the Singularity,” is a collection of alphabetically-ordered short chapters about artificial intelligence, cognitive science, genomics, information technology, nanotechnology, neuroscience, space exploration, synthetic biology, robotics, and virtual worlds. Entries range from Cloning and Cyborg Feminism to Designer Babies and Memory-Editing Drugs.” And: “If you are young and don’t remember the 1980s you should know that, before Wired magazine, the cyberculture magazine Mondo 2000 edited by R.U. Sirius covered dangerous hacking, new media and cyberpunk topics such as virtual reality and smart drugs, with an anarchic and subversive slant. As it often happens the more sedate Wired, a watered-down later version of Mondo 2000, was much more successful and went mainstream.”
Personalized medicine, the hoped-for use of the information in our genes to inform our medical care, may end up helping people live longer, healthier lives. Or it may not—the jury is still out. But one thing is certain: As our unique genomic data enter our medical records, researchers will be tempted to use that invaluable resource. The results may be good for science but bad for patients’ privacy.
In 2013, reporter Carole Cadwalladr, writing for the Guardian, described her encounter with the paradox of personalized medicine: Unlocking one’s genetic code may feel empowering, but the implications can be frightening. Cadwalladr agreed to let Illumina, a company that makes and uses gene-reading machines, sequence her DNA and use her genome in research in connection with an upcoming conference.